1-800-625-3837 1-800-625-3837 Compounded GLP-1 therapies help regulate blood sugar, reduce appetite, and promote weight loss
He became one of the first clinicians to offer the custom solution to his patients
Innovative therapeutic strategies based on GLP-1 receptor agonists (GLP-1RAs), such as tirzepatide, fixed-ratio combinations of GLP-1RA with basal insulin, combinations of GLP-1RA with sodium-glucose cotransporter-2 inhibitors (SGLT-2i), and high-dose GLP-1RAs, have been listed as one of the most effective options for the treatment of type 2 diabetes
Still, clinical decisions depend on approval status, product labeling, side effects, diabetes treatment goals, cardiovascular risk, comorbid conditions, and patient preferences